(-0.77%) 5 068.25 points
(-0.27%) 38 574 points
(-1.37%) 17 423 points
(0.17%) $82.95
(-0.54%) $1.644
(-0.39%) $2 329.20
(-0.68%) $27.16
(-0.51%) $911.10
(-0.07%) $0.934
(-0.05%) $10.98
(-0.04%) $0.802
(0.01%) $92.33
Live Chart Being Loaded With Signals
Genetic Signatures Limited operates as a molecular diagnostic (MDx) company in Australia, the Asia Pacific, the Americas, Europe, the Middle East, Israel, and Africa...
Stats | |
---|---|
Today's Volume | 75 859.00 |
Average Volume | 122 301 |
Market Cap | 126.81M |
EPS | $0 ( 2024-02-19 ) |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E | -5.67 |
ATR14 | $0 (0.00%) |
Genetic Signatures Ltd Correlation
10 Most Positive Correlations |
---|
10 Most Negative Correlations |
---|
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
Genetic Signatures Ltd Financials
Annual | 2023 |
Revenue: | $16.94M |
Gross Profit: | $-12.74M (-75.21 %) |
EPS: | $-0.0957 |
Q2 | 2024 |
Revenue: | $3.60M |
Gross Profit: | $-9.44M (-262.04 %) |
EPS: | $-0.0729 |
Q4 | 2023 |
Revenue: | $6.53M |
Gross Profit: | $-8.93M (-136.59 %) |
EPS: | $-0.0516 |
Q3 | 2022 |
Revenue: | $5.28M |
Gross Profit: | $2.29M (43.43 %) |
EPS: | $-0.0264 |
Financial Reports:
No articles found.
Genetic Signatures Ltd
Genetic Signatures Limited operates as a molecular diagnostic (MDx) company in Australia, the Asia Pacific, the Americas, Europe, the Middle East, Israel, and Africa. It designs and manufactures a suite of real-time polymerase chain reaction-based products for detection of infectious diseases under the EasyScreen brand name. The company also provides MDx 3Base platform technology that enables hospital and pathology laboratories to screen for a range of infectious pathogens. In addition, it offers detection kits for gastrointestinal infections, respiratory, sexual health, anti-microbial resistance, meningitis, and tropical disease. The company was incorporated in 2001 and is headquartered in Newtown, Australia.
About Live Signals
The live signals presented on this page help determine when to BUY or SELL NA. The signals have upwards of a 1-minute delay; like all market signals, there is a chance for error or mistakes.
The live trading signals are not definite, and getagraph.com hold no responsibility for any action taken upon these signals, as described in the Terms of Use. The signals are based on a wide range of technical analysis indicators